2019 MDMA Reimbursement Agenda


*Speakers will be added as confirmed

Click Here for a PDF of the Agenda

Wednesday, November 13, 2019

Day one of the conference consists of interactive and intensive panels that answer how medical devices are reimbursed, what it takes to establish reimbursement, and practical advice to achieve success.  These sessions will explore the foundation of medical device reimbursement (coding coverage, and payment) as these processes intersect in the current and evolving healthcare environment, and will focus on creating an implementable strategy so a product can be commercialized.  They also include real world applications, case simulations and an idea exchange with participants to discuss product-specific reimbursement questions and issues to begin to put this information into practice. 

2:30pm - 5:00pm

Reimbursement Challenges, Case Studies, Critical Strategic Planning

  • Adi Renbaum, President, ANR Consulting, LLC
  • Judy Rosenbloom, Founder & President, JR Associates
  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates

5:00pm - 6:00pm

Networking Reception

Thursday, November 14, 2019

7:30am - 8:10am

Registration & Continental Breakfast

8:10am - 8:15am 

Welcome, Opening Remarks & Introductions

  • Mark Leahey, President & CEO, MDMA

8:15am - 8:45am

HHS Opening Address

8:45am - 9:30am

CMS Update/Coverage Reforms

  • Tamara Syrek Jensen, Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services

9:30am - 10:15am

Industry Reaction Panel

  • Louis Jacques, Sr. Vice President & Chief Clinical Officer, ADVI
  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates
  • Elizabeth Halpern, Partner, Hogan Lovells (moderator)

10:15am - 10:30am

Networking Break

10:30am - 11:15am

MDMA Reimbursement Survey Results

  • Mark Domyahn, Partner, JD Lymon
  • Vrad Levering, Consultant, The Foundry & The Fogarty Institute
  • Adi Renbaum, President, ANR Consulting, LLC
  • Mark Leahey, President & CEO, MDMA (moderator)

11:15am - 12:00pm

Working with Private Insurers - Best Practices

  • Brett Logan, Consultant, Leavitt Partners, LLC
  • Barb Peterson, President & CEO, Emerson Consultants

12:00pm - 1:00pm

Buffet Lunch

1:00pm - 1:45pm

Securing Local Coverage with MACS

  • Laurence Clark, Chief Medical Director, Noridian
  • Jerry Stringham, President, Medical Technology Partners

1:45pm - 2:30pm

CMS Ombudsman Listening Session

  • James Bailey, Ombudsman, Centers for Medicare & Medicaid Services, Offices of Hearings and Inquiries (OHI)

 2:30pm - 2:45pm

Networking Break

 2:45pm - 3:30pm

Navigating CPT & RUC

  • Michael Beebe, Vice President, ADVI
  • Judy Rosenbloom, Founder & President, JR Associates

 3:30pm - 4:15pm

International Convergence: Aligning Evidence and Pricing Across the USA and
Global Markets

  • Stephen Hull, Founder, Hull Associates
  • Ed Rozynski, Senior International Advisor, MDMA



Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.